Ray TLV in 2025: The Project Bank Is Real, but 2026 Still Opens With Bridge Financing

Getting To Know The Company

Ray TLV is not a classic residential developer, and it is not a yielding real-estate company with a stable NOI profile either. It is a small land-enhancement platform, with only 9 employees, trying to assemble rights in complex urban sites in Tel Aviv, push planning, increase rights, and then monetize the land or the rights through sales or partner structures. That is why a quick look at the 2025 income statement shows almost nothing, while a quick look at the project table shows almost everything. The real issue is the bridge period.

What is working now? The company still has a meaningful project portfolio across several Tel Aviv sites, and some of them have already reached a stage where sale discussions, partner financing, or concrete planning progress are visible. Management presents an effective invested base of about NIS 152.6 million across the projects and expected net cash proceeds of about NIS 122.3 million. For a company of this scale, that is a material number and it explains why the story still attracts attention.

What is not working? 2025 ended with only NIS 240 thousand of revenue, NIS 240 thousand of cash, negative equity of NIS 8.6 million, and a working-capital deficit of NIS 22.6 million. Even that understates the near-term pressure, because the 12-month liquidity table pushes the gap to NIS 37.6 million. At the same time, credit facilities are effectively fully drawn and the company is operating through deferrals, extensions, shareholder guarantees, and capital raises. This is not a question of paper value. It is a question of timing and funding.

The easy mistake is to read the land inventory line, NIS 75.9 million, as the full story. It is not. Part of the economic exposure sits inside joint ventures such as Raul Wallenberg and Matalon, and part even depends on service agreements such as Nirim. So the consolidated balance sheet is narrower than the full project economics. But the opposite mistake is just as dangerous: the expected-cash table is also not shareholder cash. It is management’s assumption set, before tax, and before non-capitalized financing costs. That gap between created value and accessible value is the core analytical question here.

The right orientation map for Ray TLV looks like this:

Events And Triggers

March 2026 bought time, not a solution

The most important event around this report is not inside the 2025 income statement. It happened after the balance-sheet date. In late March 2026 the company completed a private placement of 35,999,673 shares and the same number of warrants, with gross proceeds of about NIS 27 million, or about NIS 25.6 million net of issuance costs. On the surface that sounds like a cleanup event. In practice, the company states explicitly that the first use of proceeds is full repayment of the Ashstrom loan, about NIS 13 million including principal and interest, with the balance earmarked for ongoing activity.

That matters because the private placement did not create a new offensive balance-sheet position. It mainly removed a more immediate pressure point. The possible move off the preservation list is still important, because the company believes the placement could help it meet the conditions for transfer to the main list, but that improves market access, not the underlying gap between planning value and available cash.

The debt-extension chain defines the story

The annual report and the immediate reports that followed tell a consistent story: 2026 opens as a refinancing year, not as a clean monetization year. The bank loan at the HaGra project, about NIS 25.9 million, was pushed from March 25, 2026 to June 25, 2026, with no change in the other terms, while the company stated that it is examining an early repayment through alternative financing. In other words, the issue was not solved. It was pushed out by three months.

At the same time, the solo non-bank lender loan, NIS 10 million of principal, was extended to March 31, 2027. But the extension came with a price. Starting September 1, 2026, the interest rate will step up by an additional 1%, on top of the current 14% annual interest plus annual credit and management fees of 5.25%. The lender also got a financial covenant at the company level, accounting equity must not fall below NIS 5 million, and a cash-sweep mechanism under which 40% of net proceeds from any debt or equity raise must go to principal repayment within three days. On top of that, extra collateral was added through the pledge of 60% of the controlling shareholders’ holdings and the extension of their personal guarantees. This is not comfortable financing. It is control financing.

The HaGra structure also includes a partner loan from Damari of about NIS 2 million, secured by a Ray guarantee and a first-ranking mortgage on the Nahalat Yitzhak rights in parcel 45. That loan was also extended to March 31, 2027. This matters because the same project that is now in commercial friction with Damari is also part of the collateral web for other financing. That creates cross-project dependency at exactly the wrong time.

Nahalat Yitzhak moved from optional upside to a friction zone

If one qualitative change stands out in this cycle, it is Nahalat Yitzhak. During October 2025 Damari filed a partition suit against all rights holders in the planning area. After that, rights holders in parcel 45 notified the company of the cancellation of the evacuation-redevelopment agreement, and the company then cancelled the associated lease agreements. By March 2026 the company was already reporting negotiations with Damari around a new commercial understanding, cancellation of the partition suit, sale of the company’s rights in the parcel, and assignment of related obligations.

The accounting and analytical consequence is immediate. In the project table the company now shows only NIS 625 thousand of invested value and NIS 625 thousand of expected net cash proceeds for Nahalat Yitzhak, and explicitly says it has, conservatively, reduced to zero the future compensation it had expected under the service agreement. That is important because, at least in this case, management did not try to defend an aggressive value when the commercial reality deteriorated.

The project portfolio can still create value, but it is not diversified in risk terms

The positive side of the story still sits inside the portfolio. Herzl is the biggest engine, with expected net cash proceeds of about NIS 47.3 million, expected gross profit of about NIS 48.1 million, and a carrying value of NIS 22.9 million. Nirim adds another NIS 34.7 million of expected net cash in management’s model, but that value sits in a service structure rather than in ordinary consolidated inventory. HaGra contributes NIS 16.8 million, Maapilei Egoz NIS 8.5 million, and Raul Wallenberg NIS 7.9 million.

The key point is that value exists, but not in a way that reduces risk. It is concentrated in a few engines, especially Herzl and Nirim. If one of them slips, the system quickly falls back into a story dominated by extensions and capital raising.

Efficiency, Profitability, And Competition

The central story of 2025 is that the company still does not have a recurring operating profit engine. In 2024 it reported about NIS 19.0 million of revenue, mostly from the sale of land at Herzl. In 2025 revenue fell to only NIS 240 thousand, almost entirely management fees. Gross profit was therefore just NIS 240 thousand. There was simply no monetization event this year strong enough to carry the report.

That makes almost every cost line material. Project initiation and development expenses were NIS 1.75 million, G&A was NIS 5.19 million, and land impairment rose to NIS 3.35 million. On the other side, other income of NIS 1.70 million included a one-off compensation item at one of the properties. The result was an operating loss of NIS 8.36 million and a net loss of NIS 11.0 million. This is not a year of weak margins. It is a year without a transaction.

The second half of the year was clearly worse than the first. In the first half of 2025 net loss was NIS 3.5 million. In the second half it widened to NIS 7.5 million. Most of the deterioration came from land impairment, which rose from NIS 0.4 million in the first half to NIS 2.95 million in the second, and from net financing costs, which climbed from NIS 0.6 million to NIS 2.67 million. This is important because it shows that the friction is not theoretical. It is already hitting reported results.

The financing line in the income statement also understates the real burden. Net financing expense recognized in profit and loss was NIS 3.27 million in 2025, but the company also capitalized NIS 4.53 million of borrowing costs into inventory. That means debt is consuming much more of the project economics than the reported P&L alone suggests. Management also explains that the increase in net financing expense was affected by the suspension of financing-cost capitalization at HaGra during the period. Once capitalization stops, more of the cost flows straight into the income statement.

On competition, the company does have a niche. It works in complex Tel Aviv land, planning, rights transfer, and small-to-medium urban assemblages. That is not a commodity market, and the ability to deal with partners, rights holders, and the municipality does matter. But it is the kind of advantage a small platform can have, not the kind of balance-sheet advantage that protects it in a difficult cycle. That is why every planning delay, partner dispute, or financing bottleneck hits this company harder than it would hit a scaled player.

Cash Flow, Debt, And Capital Structure

The cash framing here has to be all-in cash flexibility

For Ray TLV, all-in cash flexibility is the right framing. This is not a mature business where recurring cash generation can be cleanly separated from growth spending. The real question is how much cash is left after actual uses of cash, and whether that is enough to get to the next milestone.

The answer is uncomfortable. The company started 2025 with NIS 726 thousand of cash and ended with only NIS 240 thousand. Operating cash flow was negative NIS 6.53 million, investing cash flow was negative NIS 3.87 million, and the gap was covered through NIS 9.92 million of financing cash flow. Even after the May 2025 equity raise, even after new borrowings, the year still ended without a real cash cushion.

If one looks only at the standard balance-sheet classification, the working-capital deficit is NIS 22.6 million. But in the financial-instruments note the company also shows a 12-month view, and there the gap widens to NIS 37.6 million. This is one of the most important points in the report, because it makes clear that part of current assets, mainly land inventory, may be current under the operating cycle, but they are not going to solve the next 12 months of liquidity pressure.

The debt map, almost the whole system is already used

At the end of 2025 the group had about NIS 93 million of credit facilities and borrowings, and near the report date that number was already about NIS 96 million. The company states explicitly that the relevant facilities were fully utilized. That is a critical detail because it means the option of internal refinancing through unused headroom is close to zero.

The debt stack shows where the pressure sits:

There are two more layers on top of that. First, related-party loans of NIS 3.32 million, repayable out of surplus cash flow. Second, unpaid management fees to controlling shareholders. The chairman and CEO informed the company that they would defer management-fee payments until cash flow allows it, and by year-end that balance was about NIS 3.1 million. That helps the company survive, but it also shows how much it is already relying on shareholder pockets to soften the pressure.

Interest rates are themselves an active risk

The company is highly exposed to rates. It reports about NIS 77 million of prime-based debt at the consolidated level, and another roughly NIS 75 million at equity-accounted ventures, on the company’s share. According to its own sensitivity analysis, a 1% increase in rates would raise financing costs, capitalized and non-capitalized, by about NIS 1.52 million per year. In a company where the entire thesis depends on time, that is not a side note. It is one of the variables that can turn a plausible project outcome into a much tighter one.

Outlook

Before getting into the detail, there are four non-obvious conclusions that matter most:

• The real next-12-month liquidity gap is larger than the headline number. NIS 22.6 million of working-capital deficit already looks bad, but the 12-month view at NIS 37.6 million is the funding number that really matters.
• The inventory line alone understates the economics. NIS 75.9 million of consolidated land inventory does not capture the full exposure of joint ventures and service-based project economics.
• The private placement is not an operational turning point. Most of the cash is already spoken for in debt repayment and ongoing activity.
• Herzl is carrying too much of the upside case. If Herzl moves, the whole picture improves. If it stalls, the system quickly looks fragile again.

Management itself admits that monetization assumptions have been pushed out. For its office-oriented projects it states explicitly that, because of the slowdown in office-space acquisitions, especially in Tel Aviv, it reduced expected proceeds and delayed expected realization dates. That matters because it means the company is fighting not only financing pressure, but also a less forgiving end market.

The practical project map for the next year or so looks like this:

What does that amount to? 2026 looks like a bridge year, not a breakout year. For the story to improve, it is not enough that the projects are theoretically valuable. Four practical things have to happen over the next 2 to 4 quarters: the near-term HaGra debt needs to be repaid or refinanced on cleaner terms, Herzl needs binding progress with rights holders and planning, Nahalat Yitzhak needs either a new commercial arrangement or a clean exit, and the company needs to show that the private placement genuinely improved the capital structure rather than simply funding the next stretch of the same pressure.

There are still real options here. HaGra is in non-binding negotiations for a sale of the company’s full rights. At Herzl, the company already sold half the rights to Carasso in 2024, acquired additional rights in 2025, and is pushing a rights-transfer planning track under Program 2650B. At Nirim VeHashlosha, the planning documents were submitted for a final round of comments and the company expects a committee discussion during May to June 2026. The less comfortable side is that none of those items is yet cash in the bank.

Risks

The first risk is obviously financing risk. The company depends on a tight maturity schedule, high rates, shareholder guarantees, and lender consent. Recent extensions were achieved, but they are not a substitute for monetization. Any delay at one of the core projects could push the company back to the lenders’ table, this time from a weaker position.

The second risk is project concentration. Out of the NIS 122.3 million of expected net cash in management’s model, about NIS 82 million comes from Herzl and Nirim alone. That means the upside is not spread across seven equal engines. It rests mainly on two or three. In a company this small, one meaningful delay changes the entire setup.

The third risk is external execution risk. Not every bottleneck sits inside management. A large part of the path runs through the Tel Aviv municipality, planning committees, partners, rights holders, litigation, mediation, and lenders. The company itself says the war and the broader security environment already delayed planning processes, and that uncertainty in real estate and in the office market can push realization dates out even further.

The fourth risk is the gap between planning value and accessible value. Even if management is directionally right in its project table, shareholders benefit only if monetizations happen on time, if costs do not overrun, and if financing does not eat the result first. That is especially important in a company where the real financing burden is much larger than the line that appears in reported profit and loss.

The fifth risk is dependence on key people and controlling shareholders. The company itself says it is materially dependent on its two controlling managers. On top of that, parts of the financing structure rely on personal guarantees, deferred management fees, and collateral from them. That supports survival, but it also shows how far the platform still is from standing entirely on its own.

Conclusion

Ray TLV ends 2025 with two stories living in parallel. On one hand, it has a project portfolio that can create real value if it matures on management’s assumptions. On the other hand, shareholders do not live inside the expected-monetization table. They live inside the debt schedule, the rates, the collateral package, and the planning timeline. Right now the second story is still setting the pace.

Current thesis: the company owns a portfolio with meaningful potential, but 2026 will stand or fall on whether the extra time bought through capital raising and extensions can be converted into contracts, monetizations, and more stable financing.

What changed: March 2026 gave the company more time and a possible path off the preservation list, but it also exposed how deeply the financing layer already sits inside the core thesis.

Counter-thesis: if HaGra and Herzl move faster than expected, and if Nirim matures, the market may discover that it was pricing mainly the funding pressure and not the underlying project value.

What could change the market reading in the short to medium term: a clean repayment or refinancing of the nearest HaGra debt, binding progress at Herzl, and evidence that the private placement did more than just keep the system alive.

Why this matters: this is a company where future value may already exist on paper, but the path from that value to common shareholders still runs through financing, timing, and execution.

Over the next 2 to 4 quarters the company needs to close at least one of the two central gaps: either turn a major project into cash, or make the financing structure materially less aggressive and less short-dated. If that happens, the read on the shares can improve quickly. If it does not, even an interesting project portfolio will continue to look like value that exists mainly on paper.